Viewing Study NCT04962958

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-05-30 @ 5:12 PM
Study NCT ID: NCT04962958
Status: UNKNOWN
Last Update Posted: 2023-06-22
First Post: 2021-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma View
None Carcinoma, Hepatocellular View
None Liver Neoplasms View
None Digestive System Neoplasms View
None Antineoplastic Agents View
None Donafenib View
None Fluorouracil View
None Oxaliplatin View
None Antimetabolites View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma View
None Hepatic arterial infusion chemotherapy View
None Donafenib View